Back | Next |
home / stock / rdgl / rdgl message board
Subject | By | Source | When |
---|---|---|---|
Do your usual math. If x amount of | AtlasQ | investorshub | 07/01/2024 10:13:44 PM |
Stock is going back to $0.06 . | Roofus | investorshub | 07/01/2024 9:56:41 PM |
The market is waiting for IDE approval. Everything | CatfishHunter | investorshub | 07/01/2024 9:46:45 PM |
No agenda. Watching my gains disappear slowly. I | AtlasQ | investorshub | 07/01/2024 9:31:47 PM |
Yes sir. Lets hope they both rip. | Jrossco | investorshub | 07/01/2024 9:25:25 PM |
Any predictions are for the future . | Roofus | investorshub | 07/01/2024 9:15:45 PM |
Current OS is 417Mish | Cameron12221 | investorshub | 07/01/2024 9:13:55 PM |
Here we go again with the predictions. So | AtlasQ | investorshub | 07/01/2024 9:13:45 PM |
Even with a fully diluted share count of | classics99 | investorshub | 07/01/2024 9:09:17 PM |
Even $1.4 billion buyout . | Roofus | investorshub | 07/01/2024 9:09:03 PM |
Markets can remain irrational longer than you can | AtlasQ | investorshub | 07/01/2024 9:06:05 PM |
Big pharma has made plays for the space | classics99 | investorshub | 07/01/2024 9:02:06 PM |
4.4 mil volume today, clich but true, for | Rum_Tequila | investorshub | 07/01/2024 8:50:38 PM |
417,000,000ish currently | Cameron12221 | investorshub | 07/01/2024 8:34:57 PM |
Hey guys is 400,000,000 shares outstanding including the | dekeferrell | investorshub | 07/01/2024 8:30:26 PM |
Honestly, post approval, these guys should have called | Tiger Money | investorshub | 07/01/2024 7:56:58 PM |
I also think the time of the offering | Jimmlu59 | investorshub | 07/01/2024 7:56:06 PM |
Thought so who cares about the offering?! | Jimmlu59 | investorshub | 07/01/2024 7:55:11 PM |
And like the previous offerings, it wont be | CatfishHunter | investorshub | 07/01/2024 7:44:46 PM |
The offering hasnt even been approved yet. The | wrinklesobw | investorshub | 07/01/2024 7:39:42 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...